Kelsey K. Baker

1.3k total citations
43 papers, 728 citations indexed

About

Kelsey K. Baker is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Kelsey K. Baker has authored 43 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 10 papers in Surgery and 9 papers in Cancer Research. Recurrent topics in Kelsey K. Baker's work include Hematopoietic Stem Cell Transplantation (4 papers), Cancer Genomics and Diagnostics (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Kelsey K. Baker is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), Cancer Genomics and Diagnostics (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Kelsey K. Baker collaborates with scholars based in United States, Greece and United Kingdom. Kelsey K. Baker's co-authors include Steven A. Pergam, Sara Marquis, Maresa C. Woodfield, Guang‐Shing Cheng, Jesse R. Fann, Christine M. Lee, Mary W. Redman, Ted Gooley, David N. Fredricks and H. Joachim Deeg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Kelsey K. Baker

37 papers receiving 722 citations

Peers

Countries citing papers authored by Kelsey K. Baker

Since Specialization

Citations

This map shows the geographic impact of Kelsey K. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelsey K. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelsey K. Baker more than expected).

Fields of papers citing papers by Kelsey K. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelsey K. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelsey K. Baker. The network helps show where Kelsey K. Baker may publish in the future.

Co-authorship network of co-authors of Kelsey K. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Kelsey K. Baker. A scholar is included among the top collaborators of Kelsey K. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelsey K. Baker. Kelsey K. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoadjuvant pembrolizumab (pembro) and accelerated methotrexate, vinblastine, doxorubicin, cisplatin (aMVAC) in non-urothelial (non-UC) histologic subtype muscle invasive bladder cancer (MIBC): A phase 2 trial. 2025 ·Journal of Clinical Oncology ·(unknown), Ali Raza Khaki, Mary W. Redman, Kelsey K. Baker, (unknown), (unknown), (unknown), (unknown), Funda Vakar‐Lopez, Todd Yezefski, Michael T. Schweizer, Bruce Montgomery, Evan Y. Yu, Atreya Dash, Sarah P. Psutka, Dingbo Lin, George R. Schade, John L. Gore, Jonathan L. Wright, Petros Grivas	0
2	Phase I/Ib study of afatinib with capecitabine in patients with refractory solid tumors and pancreaticobiliary cancers. 2025 ·Journal of Clinical Oncology ·Gentry Teng King, Kelsey K. Baker, Andrew L. Coveler, Rachael A. Safyan, Kit Man Wong, Veena Shankaran, David B. Zhen, (unknown), (unknown), (unknown), Greg Andrew Durm, Mary W. Redman, Colin C. Pritchard, Safi Shahda, E. Gabriela Chiorean	1
3	Prevalence and Economic Burden of Osteoarthritis and Rheumatoid Arthritis in the Medically Underserved Rio Grande Valley: A Retrospective Longitudinal Analysis 2024 ·Cureus ·(unknown), (unknown), (unknown), (unknown), (unknown), Elizabeth Bergman, Kelsey K. Baker, Bharathi S. Gadad	0
4	B7-H3 is widely expressed in soft tissue sarcomas 2024 ·BMC Cancer ·(unknown), (unknown), (unknown), Borislav A. Alexiev, Eleanor Y. Chen, (unknown), Brett Schroeder, Kelly L. Hudkins, Timothy M. Fan, Mary W. Redman, Kelsey K. Baker, George Jour, Lee D. Cranmer, Seth M. Pollack	2
5	Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic 2024 ·JAMA Network Open ·Anthony L. Back, (unknown), David L. Morgan, (unknown), Kelsey K. Baker, (unknown), Bonnie A. McGregor, (unknown), (unknown), (unknown), Brandon J. Thomas, (unknown), Mendel Kaelen, Benjamin Kelmendi, Ted Gooley	9
6	Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas 2023 ·Cancer Epidemiology Biomarkers & Prevention ·Ming Yu, Kelly Carter, Kelsey K. Baker, Mary W. Redman, Ting Wang, (unknown), Christopher I. Li, Stacey A. Cohen, Mukta Krane, Jennifer Ose, Biljana Gigic, Jane C. Figueiredo, Adetunji T. Toriola, Erin M. Siegel, David Shibata, Martin Schneider, Cornelia M. Ulrich, (unknown), Robert E. Schoen, William M. Grady	3
7	An Avatar-Led Web-Based and SMS Text Message Smoking Cessation Program for Socioeconomically Disadvantaged Veterans: Pilot Randomized Controlled Trial 2023 ·JMIR Formative Research ·Jaimee L. Heffner, Megan M. Kelly, Erin D. Reilly, (unknown), (unknown), (unknown), Kelsey K. Baker, Noreen L Watson, Maria Karekla	7
8	610 ImmunoRad: a stratified phase II trial of image guided hypofractionated radiotherapy with concurrent nelfinavir & PD-1 inhibition in advanced melanoma, lung cancer & renal cell carcinoma 2023 ·SHILAP Revista de lepidopterología ·Peter H. Goff, Kelsey K. Baker, Sylvia M. Lee, Scott S. Tykodi, Shailender Bhatia, Jing Zeng, Mary W. Redman, Ramesh Rengan	0
9	Racial and sex differences in tumor genomics in urothelial carcinoma 2023 ·Urologic Oncology Seminars and Original Investigations ·Yaw A. Nyame, Kelsey K. Baker, Bruce Montgomery, Petros Grivas, Mary W. Redman, Jonathan L. Wright	0
10	Racial disparities in the screening mammography continuum within a heterogeneous health care system 2023 ·Cancer ·(unknown), Kelsey K. Baker, Mary W. Redman, Adelaide H. McClintock, Rachel L. Yung	12
11	Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies 2022 ·Transplantation and Cellular Therapy ·Christina Ullrich, Kelsey K. Baker, Paul A. Carpenter, Mary E.D. Flowers, Ted Gooley, (unknown), Elizabeth F. Krakow, Masumi Ueda, Rachel B. Salit, (unknown), Laura Connelly‐Smith, Stephanie J. Lee, William A. Wood	8
12	An Avatar-Led Digital Smoking Cessation Program for Sexual and Gender Minority Young Adults: Intervention Development and Results of a Single-Arm Pilot Trial 2021 ·JMIR Formative Research ·Jaimee L. Heffner, Noreen L Watson, (unknown), Megan M. Kelly, Erin D. Reilly, (unknown), Kelsey K. Baker, NFN Scout, Maria Karekla	16
13	HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide 2020 ·Biology of Blood and Marrow Transplantation ·Kanwaldeep Mallhi, (unknown), Kelsey K. Baker, Haydar Frangoul, Troy R. Torgerson, Aleksandra Petrovič, Amy E. Geddis, Paul A. Carpenter, K. Scott Baker, Brenda M. Sandmaier, Monica S. Thakar, Suzanne Skoda‐Smith, Hans‐Peter Kiem, Rainer Storb, Ann E. Woolfrey, Lauri M. Burroughs	20
14	Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis 2019 ·Bone Marrow Transplantation ·Rachel B. Salit, Bart L. Scott, Emily A. Stevens, Kelsey K. Baker, Ted Gooley, H. Joachim Deeg	34
15	Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer—A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib 2018 ·Clinical Breast Cancer ·(unknown), Hannah M. Linden, Vijayakrishna K. Gadi, Larissa A. Korde, Eve T. Rodler, Julie R. Gralow, Mary W. Redman, Kelsey K. Baker, Qian Wu, Isaac Jenkins, Brenda F. Kurland, Mitchell Garrison, Julie C. Smith, Jeanne E. Anderson, (unknown), Jennifer M. Specht	29
16	Differential Outcomes Among Immunosuppressed Patients With Merkel Cell Carcinoma 2018 ·American Journal of Clinical Oncology ·(unknown), Kelsey K. Baker, Mary W. Redman, Kristina Lachance, (unknown), Upendra Parvathaneni, Shailender Bhatia, Paul Nghiem, Yolanda D. Tseng	41
17	Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer 2017 ·British Journal of Cancer ·Zixu Yuan, Kelsey K. Baker, Mary W. Redman, Lei Wang, Scott V. Adams, Ming Yu, (unknown), Karen W. Makar, (unknown), Jürgen Böhm, Michelle A. Wurscher, Maria Westerhoff, (unknown), Ravi Moonka, Mika Sinanan, Alessandro Fichera, (unknown), William M. Grady	42
18	Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders 2017 ·Biology of Blood and Marrow Transplantation ·Lauri M. Burroughs, Akiko Shimamura, Julie‐An Talano, Jennifer Domm, Kelsey K. Baker, Colleen Delaney, Haydar Frangoul, David A. Margolis, K. Scott Baker, Eneida R. Nemecek, Amy E. Geddis, Brenda M. Sandmaier, H. Joachim Deeg, Rainer Storb, Ann E. Woolfrey	37
19	Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation 2017 ·Biology of Blood and Marrow Transplantation ·Abir Bhattacharyya, Laïla‐Aïcha Hanafi, Alyssa Sheih, Jonathan L. Golob, Sujatha Srinivasan, Michael Boeckh, Steven A. Pergam, Sajid Mahmood, Kelsey K. Baker, Ted Gooley, Filippo Milano, David N. Fredricks, Stanley R. Riddell, Cameron J. Turtle	65
20	The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases 2017 ·Clinical Epigenetics ·Stacey A. Cohen, Ming Yu, Kelsey K. Baker, Mary W. Redman, Chen Wu, (unknown), Ralph M. Wirtz, Elpida Charalambous, George Pentheroudakis, Vassiliki Kotoula, Konstantine T. Kalogeras, George Fountzilas, William M. Grady	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact